Use of palivizumab is underestimated in the Swedish Prescribed Drug Register - implications for register-based drug studies.
about
The Danish National Prescription Registry in studies of a biological pharmaceutical: palivizumab - validation against two external data sources.Do biological disease-modifying antirheumatic drugs reduce the spinal fracture risk related to ankylosing spondylitis? A longitudinal multiregistry matched cohort study.
P2860
Use of palivizumab is underestimated in the Swedish Prescribed Drug Register - implications for register-based drug studies.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Use of palivizumab is underest ...... r register-based drug studies.
@ast
Use of palivizumab is underest ...... r register-based drug studies.
@en
Use of palivizumab is underest ...... r register-based drug studies.
@nl
type
label
Use of palivizumab is underest ...... r register-based drug studies.
@ast
Use of palivizumab is underest ...... r register-based drug studies.
@en
Use of palivizumab is underest ...... r register-based drug studies.
@nl
prefLabel
Use of palivizumab is underest ...... r register-based drug studies.
@ast
Use of palivizumab is underest ...... r register-based drug studies.
@en
Use of palivizumab is underest ...... r register-based drug studies.
@nl
P2093
P2860
P356
P1476
Use of palivizumab is underest ...... or register-based drug studies
@en
P2093
Ann Haerskjold
Camilla Byström
Gunnar Bergman
Helle Kieler
P2860
P356
10.2147/CLEP.S73337
P407
P50
P577
2014-12-29T00:00:00Z